2024-11-20 09:20:18
RedHill Biopharma Announces Two New U.S. Patents Covering Opaganib for Ebola Virus and RHB-104 for Crohn's
Corporate/ 2023-07-23
RedHill Biopharma Announces Two New U.S....

U.S. patents for opaganib combination for the treatment of Ebola virus disease provides patent protection until 2035

WuXi Biologics Reports Strong 2021 Interim Results
Corporate/ 2023-07-23
WuXi Biologics Reports Strong 2021 Inter...

Revenue Increases by 126.7% Y-o-Y to RMB4,406.8 Million Gross Profit Grows by 191.7% Y-o-Y to RMB2,296.8 Million

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release